Neisseria meningitidis serogroup A polysaccharide capsule — Drug Target
All drugs that target Neisseria meningitidis serogroup A polysaccharide capsule — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Meningococcal A conjugate vaccine · PATH · Conjugate vaccine · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup A by presenting the bacterial polysaccharide capsule conjugated to a protein carrier.